|

STX-0712 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Solu Therapeutics, Inc1

Indications

  • Acute Monocytic Leukemia1
  • Refractory Acute Myeloid Leukemia (AML)1
  • Acute Myeloid Leukemias1
  • Acute Myeloid Leukemia Post Cytotoxic Therapy1
  • CMML1

Stanford, California1 trial

A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

Stanford University

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.